Cargando…

Influence of nutritional intervention on children with type 1 diabetes mellitus and DPP-4 in serum

The level of dipeptidyl peptidase-4 (DPP-4) of children with type 1 diabetes mellitus (T1DM) was observed to evaluate the improvement in function of the nutritional intervention. In total, 132 children with T1DM (T1DM group) and 132 healthy children (NC group) based on physical examination admitted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Yan-Jun, Liu, Li-Juan, Chen, Hui-Ming, Sun, Jing, Xiao, Ming-Hua, Wu, Jin-Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526184/ https://www.ncbi.nlm.nih.gov/pubmed/28781616 http://dx.doi.org/10.3892/etm.2017.4575

Ejemplares similares

DPP-4 Inhibitors as Treatments for Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: Wang, Qixian, et al.
Publicado: (2018)

DPP-4 Inhibitors Improve Liver Dysfunction in Type 2 Diabetes Mellitus
por: Kanazawa, Ippei, et al.
Publicado: (2014)

Saxagliptin: A Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
por: Shubrook, Jay, et al.
Publicado: (2011)

Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects
por: Ahmed, Radwan H., et al.
Publicado: (2016)

DPP4 Gene Polymorphism Associates With Type 2 Diabetes Mellitus in Older Adults
por: Alves, Elisa, et al.
Publicado: (2020)

Evaluation of efficacy and safety of DPP-4 inhibitors for Chinese elderly patients with type 2 diabetes mellitus
por: Yu, Dong-Ni, et al.
Publicado: (2020)

Medicinal Chemistry and Applications of Incretins and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
por: Lotfy, Mohamed, et al.
Publicado: (2011)

The Dipeptidyl Peptidase (DPP)-4 Inhibitors for Type 2 Diabetes Mellitus in Challenging Patient Groups
por: Kountz, David
Publicado: (2013)

Nutritional intervention for diabetes mellitus with Alzheimer's disease
por: Li, Zhi, et al.
Publicado: (2022)

Systematic Literature Review of DPP-4 Inhibitors in Patients with Type 2 Diabetes Mellitus and Renal Impairment
por: Thomas, Merlin C., et al.
Publicado: (2016)

The cost‐effectiveness of dapagliflozin compared to DPP‐4 inhibitors in the treatment of type 2 diabetes mellitus in the Netherlands
por: Van der Linden, N., et al.
Publicado: (2020)

Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus
por: Sim, A Young, et al.
Publicado: (2021)

DPP4 in Diabetes
por: Röhrborn, Diana, et al.
Publicado: (2015)

Renal Protective Effect of DPP-4 Inhibitors in Type 2 Diabetes Mellitus Patients: A Cohort Study
por: Kim, Young-Gun, et al.
Publicado: (2016)

The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect
por: Makrilakis, Konstantinos
Publicado: (2019)

Impact of DPP-4 inhibitors on plasma levels of BNP and NT-pro-BNP in type 2 diabetes mellitus
por: Mu, Liying, et al.
Publicado: (2022)

Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity
por: Lee, Jae-Geun, et al.
Publicado: (2011)

Association and interaction analysis of PPARGC1A and serum uric acid on type 2 diabetes mellitus in Chinese Han population
por: Wu, Hui-Hui, et al.
Publicado: (2014)

Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention
por: Badawi, Alaa, et al.
Publicado: (2010)

Influence of Type 1 Diabetes Mellitus on the Ocular Biometry of Chinese Children
por: Xiao, Ying, et al.
Publicado: (2019)

Retrospective Analysis of Long-Term Adherence to and Persistence with DPP-4 Inhibitors in US Adults with Type 2 Diabetes Mellitus
por: Farr, Amanda M., et al.
Publicado: (2014)

Assessing Scientific Soundness and Translational Value of Animal Studies on DPP4 Inhibitors for Treating Type 2 Diabetes Mellitus
por: Franco, Nuno Henrique, et al.
Publicado: (2021)

Does DPP-4 inhibitor treatment affect the clinical outcomes of COVID-19 in type 2 diabetes mellitus patients?
por: Erol, Rumeysa Selvinaz, et al.
Publicado: (2022)

Low Serum Dehydroepiandrosterone Is Associated With Diabetic Kidney Disease in Men With Type 2 Diabetes Mellitus
por: Zhang, Xinxin, et al.
Publicado: (2022)

Glutathione Peroxidase 4 Is a Predictor of Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus
por: Wang, Yi-hui, et al.
Publicado: (2022)

CD26/DPP-4: Type 2 Diabetes Drug Target with Potential Influence on Cancer Biology
por: Kawakita, Emi, et al.
Publicado: (2021)

DPP4 Deficiency Preserved Cardiac Function in Abdominal Aortic Banding Rats
por: Ku, Hui-Chun, et al.
Publicado: (2014)

Serum Ferritin Independently Predicts the Incidence of Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus
por: Wu, Yun Hong, et al.
Publicado: (2020)

Effects of lifestyle interventions on rural patients with type 2 diabetes mellitus
por: Wang, Bo, et al.
Publicado: (2020)

Serum Zinc Levels in Children and Adolescents with Type-1 Diabetes Mellitus
por: Estakhri, M, et al.
Publicado: (2011)

Associations of visit-to-visit variabilities and trajectories of serum lipids with the future probability of type 2 diabetes mellitus
por: Sun, Qian, et al.
Publicado: (2021)

Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin
por: Ahrén, Bo
Publicado: (2010)

Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes
por: Gallwitz, Baptist
Publicado: (2013)

Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes
por: Kishimoto, Miyako
Publicado: (2013)

Nutritional Effects of the Enteral Nutritional Formula on Regulation of Gut Microbiota and Metabolic Level in Type 2 Diabetes Mellitus Mice
por: Wei, Ting, et al.
Publicado: (2021)

The Impact of Intestinal Microorganisms and Their Metabolites on Type 1 Diabetes Mellitus
por: Zheng, Shu-Juan, et al.
Publicado: (2022)

Low serum dehydroepiandrosterone levels are associated with diabetic retinopathy in patients with type 2 diabetes mellitus
por: Zhang, Xinxin, et al.
Publicado: (2023)

Medium-Term Effect of Add-On Therapy with the DPP-4 Inhibitor, Sitagliptin, in Insulin-Treated Japanese Patients with Type 2 Diabetes Mellitus
por: Katsuno, Tomoyuki, et al.
Publicado: (2016)

DPP-4 Inhibitor in Type 2 Diabetes Mellitus Patient with Non-Alcoholic Fatty Liver Disease: Achieving Two Goals at Once?
por: Bae, Ji Cheol
Publicado: (2022)

Dipeptidyl Peptidase (DPP)-4 Inhibitor Impairs the Outcomes of Patients with Type 2 Diabetes Mellitus After Curative Resection for Colorectal Cancer
por: Saito, Akira, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_la9lgn6bvdkhgjf82jdhcq671n